The outlook of companies tied to the drug's past presents a intricate investment landscape. While the initial success generated substantial returns , generic alternatives have significantly diminished market https://bookmarkingdelta.com/story21589210/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity